A detailed history of Dimensional Fund Advisors LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 956,785 shares of HRMY stock, worth $39.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
956,785
Previous 844,588 13.28%
Holding current value
$39.7 Million
Previous $28.4 Million 1.78%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$28.81 - $33.01 $3.23 Million - $3.7 Million
112,197 Added 13.28%
956,785 $28.9 Million
Q1 2024

May 10, 2024

BUY
$29.93 - $35.06 $3.24 Million - $3.8 Million
108,320 Added 14.71%
844,588 $28.4 Million
Q4 2023

Feb 07, 2024

SELL
$19.2 - $33.78 $924,979 - $1.63 Million
-48,176 Reduced 6.14%
736,268 $23.8 Million
Q3 2023

Nov 09, 2023

BUY
$31.89 - $39.03 $1.65 Million - $2.03 Million
51,893 Added 7.08%
784,444 $25.7 Million
Q2 2023

Aug 09, 2023

SELL
$30.5 - $37.4 $3.03 Million - $3.72 Million
-99,476 Reduced 11.96%
732,551 $25.8 Million
Q1 2023

May 12, 2023

BUY
$30.8 - $53.92 $7.75 Million - $13.6 Million
251,623 Added 43.35%
832,027 $27.2 Million
Q4 2022

Feb 09, 2023

BUY
$45.4 - $60.91 $800,583 - $1.07 Million
17,634 Added 3.13%
580,404 $32 Million
Q3 2022

Nov 10, 2022

BUY
$42.06 - $55.45 $4.42 Million - $5.83 Million
105,082 Added 22.96%
562,770 $24.9 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $3.74 Million - $5.82 Million
111,636 Added 32.26%
457,688 $22.3 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $5 Million - $7.72 Million
150,931 Added 77.35%
346,052 $16.8 Million
Q4 2021

Feb 09, 2022

BUY
$34.09 - $43.91 $5.41 Million - $6.97 Million
158,725 Added 436.11%
195,121 $8.32 Million
Q3 2021

Nov 12, 2021

BUY
$25.68 - $38.61 $934,649 - $1.41 Million
36,396 New
36,396 $1.4 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.45B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.